Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors

Completed · Not applicable

Conditions studied: Breast Carcinoma, Cancer Survivor, Depression, Fatigue, Leukemia, Lymphoma, Malignant Bone Neoplasm, Malignant Digestive System Neoplasm, Malignant Female Reproductive System Neoplasm, Malignant Male Reproductive System Neoplasm, Pain, Sleep Disorder, Soft Tissue Sarcoma

In brief

This randomized clinical trial studies survivorship care in reducing symptoms in young adult cancer survivors. Survivorship care programs that identify the needs of young adult cancer survivors and ways to support them through the years after treatment may help reduce symptoms, such as pain, fatigue, sleep disturbance, depression, and distress, in young adult cancer survivors.

Key facts

Study ID

NCT02192333

Run by

Fred Hutchinson Cancer Center

People needed

390

Starts

2015-08-03

Expected to finish

2019-12-31

Last updated by the study team

2020-10-09

Who can join

Age: 18 and older, up to 39. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients enrolled on phase 1 of the study are eligible (and/or if recruited from tumor registry or clinic follow-up schedules)
• Diagnosed with invasive malignancy including: breast, gastrointestinal track, female or male genitourinary system, sarcoma of bone or soft-tissue, leukemia and lymphoma
• Treated at one of the Survivorship Centers of Excellence or their community affiliates
• Received a therapeutic intervention with at least one of the following modalities: surgery, cytotoxic chemotherapy, biological or targeted agents, radiation therapy (any modality)
• Currently between 1.0 and 4.99 years from the completion of active cancer-directed therapy (cytotoxic chemotherapy, radiation therapy and/or definitive surgical intervention)
• Patient must still be in active follow-up: seen for a follow-up visit in the participating center at least once in the 3 years prior to enrollment and/or scheduled to be seen for follow-up in the next 6 months (i.e. in active follow-up)
• May be receiving "maintenance" therapy that has a goal of prevention of recurrence but there should be no expectations for further active treatment
• Able to read and speak English adequate to complete the patient-reported outcomes (PRO) assessment

You may not qualify if…

• Prior visit to a survivorship clinic or previously provided with a treatment summary and care plan

Where it is running

• UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California, United States
• University of Colorado Cancer Center - Anschutz Cancer Pavilion — Aurora, Colorado, United States
• Dana-Farber Cancer Institute — Boston, Massachusetts, United States
• UNC Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina, United States
• University of Pennsylvania/Abramson Cancer Center — Philadelphia, Pennsylvania, United States
• Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.